RT Journal Article
SR Electronic
A1 Vinall, Maria
T1 Tirofiban Significantly Reduces Myocardial Damage after PCI Compared with Standard Antiplatelet Therapy
JF MD Conference Express
YR 2008
FD SAGE Publications
VO 8
IS 6
SP 23
OP 24
DO 10.1177/155989770800800614
UL http://mdc.sagepub.com/content/8/6/23.abstract
AB Results from the 3T/2R study [NCT00398463] demonstrated that the addition of tirofiban to standard therapy decreased the rate of myocardial infarction and resulted in a lower rate of major cardiovascular events 30 days after percutaneous coronary intervention compared with standard antiplatelet therapy alone in poor responders to aspirin or clopidogrel.